Literature DB >> 22727705

Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.

Derek J Fisher1, Alain Labelle, Verner J Knott.   

Abstract

Auditory verbal hallucinations (AHs), or hearing 'voices', are one of the hallmark symptoms of patients with schizophrenia. The primary objective of this study was to compare hallucinating schizophrenia patients with respect to differences in deviance detection, as indexed by the auditory mismatch negativity (MMN). Patients were recruited during an acute psychotic episode requiring hospitalization, during which time symptoms of psychosis, including auditory hallucinations, are likely to be at their most severe. MMNs to duration, frequency, gap, intensity and location deviants (as elicited by the 'optimal' multi-feature paradigm) were recorded in 12 acutely ill schizophrenia patients (SZ) with persistent AHs and 15 matched healthy controls (HC). Electrical activity was recorded from 32 scalp electrodes. MMN amplitudes and latencies for each deviant were compared between groups and were correlated with trait (PSYRATS) and state measures of AH severity and Positive and Negative Syndrome Scale (PANSS) ratings in SZs. There were significant group differences for duration, gap, intensity and location MMN amplitudes, such that SZs exhibited reduced MMNs compared to HCs. Additionally, gap MMN amplitudes were correlated with measures of hallucinatory state and frequency of AHs, while location MMN was correlated with perceived location of AHs. In summary, this study corroborates previous research reporting a robust duration MMN deficit in schizophrenia, as well as reporting gap, intensity and location MMN deficits in acutely ill schizophrenia patients with persistent AHs. Additionally, MMN amplitudes were correlated with state and trait measures of AHs. These findings offer further support to previous work suggesting that the presence of auditory hallucinations may make a significant contribution to the widely reported MMN deficits in schizophrenia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727705     DOI: 10.1016/j.schres.2012.06.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.

Authors:  Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt
Journal:  Schizophr Res       Date:  2017-07-11       Impact factor: 4.939

2.  Hallucinations, neuroplasticity, and prediction errors in schizophrenia.

Authors:  Amanda McCleery; Jonathan K Wynn; Daniel H Mathalon; Michael F Green
Journal:  Scand J Psychol       Date:  2018-02

Review 3.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

4.  Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.

Authors:  Rachel A Hay; Brian J Roach; Vinod H Srihari; Scott W Woods; Judith M Ford; Daniel H Mathalon
Journal:  Biol Psychol       Date:  2015-01-17       Impact factor: 3.251

5.  Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.

Authors:  Danielle Impey; Ashley Baddeley; Renee Nelson; Alain Labelle; Verner Knott
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

6.  Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration.

Authors:  Ashley M Francis; Andrea Parks; Joëlle Choueiry; Nicole El-Marj; Danielle Impey; Verner J Knott; Derek J Fisher
Journal:  Psychopharmacology (Berl)       Date:  2021-05-01       Impact factor: 4.530

7.  French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms.

Authors:  Jerome Favrod; Shyhrete Rexhaj; Pascale Ferrari; Sabrina Bardy; Claude Hayoz; Stéphane Morandi; Charles Bonsack; Fabienne Giuliani
Journal:  BMC Psychiatry       Date:  2012-09-28       Impact factor: 3.630

8.  Inhibitory Top-Down Control Deficits in Schizophrenia With Auditory Verbal Hallucinations: A Go/NoGo Task.

Authors:  Qiaoling Sun; Yehua Fang; Yongyan Shi; Lifeng Wang; Xuemei Peng; Liwen Tan
Journal:  Front Psychiatry       Date:  2021-06-04       Impact factor: 4.157

9.  Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.

Authors:  Verner Knott; Dhrasti Shah; Anne Millar; Judy McIntosh; Derek Fisher; Crystal Blais; Vadim Ilivitsky
Journal:  Front Pharmacol       Date:  2012-09-28       Impact factor: 5.810

10.  Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders.

Authors:  Kayla R Donaldson; Keisha D Novak; Dan Foti; Maya Marder; Greg Perlman; Roman Kotov; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.